Capillary malformation-arteriovenous malformation

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:137667OMIM:608354Q27.3
Who is this for?
Show terms as
20Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Capillary malformation-arteriovenous malformation (CM-AVM) is a rare inherited vascular disorder characterized by the presence of multiple small, round, pinkish-red capillary malformations (CMs) scattered across the skin, often surrounded by a pale halo. These cutaneous lesions are typically present from birth and can be found on the face, limbs, and trunk. A significant proportion of affected individuals—estimated at approximately 30%—also develop fast-flow vascular lesions, including arteriovenous malformations (AVMs) or arteriovenous fistulas (AVFs), which can occur in the brain, spine, skin, muscle, or bone. These fast-flow lesions carry a risk of serious complications such as hemorrhage, heart failure, or neurological deficits depending on their location. CM-AVM is caused by heterozygous loss-of-function mutations in the RASA1 gene (CM-AVM1, also known as CM-AVM syndrome type 1) or the EPHB4 gene (CM-AVM2, CM-AVM syndrome type 2). Both genes encode proteins involved in the RAS/MAPK signaling pathway, which plays a critical role in blood vessel development and maintenance. The condition follows autosomal dominant inheritance with variable expressivity and incomplete penetrance, meaning that family members carrying the same mutation may have very different clinical presentations. Diagnosis is based on clinical findings and confirmed through molecular genetic testing. Management requires a multidisciplinary approach involving dermatologists, interventional radiologists, neurologists, and vascular surgeons. Screening for intracranial and spinal AVMs is recommended, particularly in children, given the risk of life-threatening bleeding. Treatment of AVMs may include embolization or surgical excision depending on the size, location, and symptoms. Capillary malformations themselves are generally benign and may be treated with pulsed dye laser therapy for cosmetic purposes. There is currently no cure, and management focuses on surveillance and treatment of complications.

Also known as:

Clinical phenotype terms— hover any for plain English:

Capillary malformationHP:0025104Vascular skin abnormalityHP:0011276TelangiectasiaHP:0001009High-output congestive heart failureHP:0001722Cerebral arteriovenous malformationHP:0002408Cerebral ischemiaHP:0002637Arteriovenous fistulaHP:0004947Abnormality of the musculature of the limbsHP:0009127Vein of Galen aneurysmal malformationHP:0030713Arteriovenous malformationHP:0100026Abnormality of the lymphatic systemHP:0100763Peripheral arteriovenous fistulaHP:0100784Neurogenic bladderHP:0000011Facial capillary hemangiomaHP:0000996
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Capillary malformation-arteriovenous malformation.

View clinical trials →

No actively recruiting trials found for Capillary malformation-arteriovenous malformation at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Capillary malformation-arteriovenous malformation community →

Specialists

20 foundView all specialists →
BS
Bin Sun
TUCSON, AZ
Specialist
1 Capillary malformation-arteriovenous malformation publication
AB
Anna Trier Heiberg Brix
Specialist
1 Capillary malformation-arteriovenous malformation publication
XL
Xiaoxi Lin
NEW YORK, NY
Specialist
1 Capillary malformation-arteriovenous malformation publication
CH
Chen Hua
Specialist
1 Capillary malformation-arteriovenous malformation publication
YJ
Yunbo Jin
Specialist
1 Capillary malformation-arteriovenous malformation publication
HC
Hongrui Chen
Specialist
1 Capillary malformation-arteriovenous malformation publication
EB
Eulàlia Baselga
Specialist
2 Capillary malformation-arteriovenous malformation publications
YC
Yuxi Chen
BRONX, NY
Specialist
1 Capillary malformation-arteriovenous malformation publication
HL
Hongyuan Liu
Specialist
1 Capillary malformation-arteriovenous malformation publication
JZ
Jingwei Zhou
Specialist
1 Capillary malformation-arteriovenous malformation publication
XY
Xi Yang
Specialist
1 Capillary malformation-arteriovenous malformation publication
HJ
Hechen Jia
Specialist
1 Capillary malformation-arteriovenous malformation publication
GM
Gang Ma
Specialist
1 Capillary malformation-arteriovenous malformation publication
DM
Douglas R Stewart, M.D.
Bethesda, Maryland
Specialist

Rare Disease Specialist

PI on 5 active trials
EB
Ekaterina M Listovskaya, BSc
Specialist
PI on 1 active trial
AB
Anette Bygum
Specialist
1 Capillary malformation-arteriovenous malformation publication
PT
Pernille Mathiesen Tørring
Specialist
1 Capillary malformation-arteriovenous malformation publication
AM
Alexander Dmitriev, MD
Specialist
PI on 4 active trials1 Capillary malformation-arteriovenous malformation publication
SF
SENG-JIN YEO, FRCS
Specialist
PI on 1 active trial
WZ
Weihui Zeng
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Capillary malformation-arteriovenous malformation.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Capillary malformation-arteriovenous malformationForum →

No community posts yet. Be the first to share your experience with Capillary malformation-arteriovenous malformation.

Start the conversation →

Latest news about Capillary malformation-arteriovenous malformation

1 articles
NewsRSSApr 22, 2026
When Your Doctor Knows Your Story: Saying Goodbye to a Partner in My ATTR-CM Journey
A patient with ATTR-CM (a rare heart disease caused by abnormal protein buildup) is sharing their experience saying goodbye to a doctor who understood their con
See all news about Capillary malformation-arteriovenous malformation

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Capillary malformation-arteriovenous malformation

What is Capillary malformation-arteriovenous malformation?

Capillary malformation-arteriovenous malformation (CM-AVM) is a rare inherited vascular disorder characterized by the presence of multiple small, round, pinkish-red capillary malformations (CMs) scattered across the skin, often surrounded by a pale halo. These cutaneous lesions are typically present from birth and can be found on the face, limbs, and trunk. A significant proportion of affected individuals—estimated at approximately 30%—also develop fast-flow vascular lesions, including arteriovenous malformations (AVMs) or arteriovenous fistulas (AVFs), which can occur in the brain, spine, ski

How is Capillary malformation-arteriovenous malformation inherited?

Capillary malformation-arteriovenous malformation follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Capillary malformation-arteriovenous malformation typically begin?

Typical onset of Capillary malformation-arteriovenous malformation is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Capillary malformation-arteriovenous malformation?

20 specialists and care centers treating Capillary malformation-arteriovenous malformation are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.